Drug recall · August 14, 2013
Ondansetron Injection recall
Why: Presence of Particulate; lot being recalled as a precaution due to the discovery of 2 particles found in a lot which preceded the recalled lot
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ondansetron Injection, USP, 4mg/2mL, (2mg/ml), 2mL single-dose Fliptop Vial, Rx only, Sterile, NDC 0409-4755-03, Hospira, Inc, Lake Forest, IL 60045.
- Lots / codes
Lot 25394DK, exp. 01/2015
- Quantity
- 340,600 vials
- Company
- Hospira, Inc., Lake Forest, IL
- Distribution
- Nationwide
- Initiated
- May 20, 2013 · Voluntary: Firm initiated
- Classified
- August 7, 2013
- Reported
- August 14, 2013
- Ended
- October 28, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ondansetron
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.